SF3B1 mutation predicts unfavorable treatment-free survival in Chinese chronic lymphocytic leukemia patients

BACKGROUND: Splicing factor 3b subunit 1 (SF3B1), a splicing factor modulating RNA alternative splicing, is frequently mutated in multiple hematological malignancies including myelodysplastic syndromes and chronic lymphocytic leukemia (CLL). The clinical impact of SF3B1 mutation on CLL remains contr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Transl Med
Asıl Yazarlar: Miao, Yi, Zou, Yi-Xin, Gu, Dan-Ling, Zhu, Hong-Cheng, Zhu, Hua-Yuan, Wang, Li, Liang, Jin-Hua, Xia, Yi, Wu, Jia-Zhu, Shao, Chun-Lin, Fan, Lei, Zhang, Zhen, Xu, Wei, Li, Jian-Yong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6526254/
https://ncbi.nlm.nih.gov/pubmed/31168457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.03.63
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller